Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 19.88 | 4.44 | 1.02 | 0.10 |
Depreciation/ Depletion | 2.05 | 1.84 | 1.66 | 1.47 |
Non- Cash Items | -0.50 | -0.24 | 0.25 | -0.03 |
Changesin Working Capital | -26.63 | -2.87 | 5.06 | -1.00 |
Cashfrom Operating Activities | -5.20 | 3.17 | 7.99 | 0.54 |
Capital Expenditures | -1.76 | -4.49 | -1.55 | -1.79 |
Other Investing Cash Flow Items Total | 0.56 | 0.06 | 0.02 | -0.10 |
Cashfrom Investing Activities | -1.20 | -4.43 | -1.53 | -1.89 |
Financing Cash Flow Items | -0.29 | -0.26 | -0.28 | 0.00 |
Total Cash Dividends Paid | -0.07 | -0.07 | 0.00 | - |
Issuance( Retirement)of Stock Net | 13.87 | 4.63 | 0.00 | - |
Issuance( Retirement)of Debt Net | -1.11 | 0.64 | -6.39 | 1.74 |
Cashfrom Financing Activities | 12.41 | 4.94 | -6.68 | 1.74 |
Net Changein Cash | 6.01 | 3.68 | -0.21 | 0.38 |
Cash Interest Paid | 0.29 | 0.26 | 0.28 | 0.01 |
Cash Taxes Paid | 0.62 | 0.25 | 0.44 | 0.00 |
Shukra Pharmaceuticals Dividend Shukra Pharmaceuticals Bonus Shukra Pharmaceuticals News Shukra Pharmaceuticals AGM Shukra Pharmaceuticals Rights Shukra Pharmaceuticals Splits Shukra Pharmaceuticals Board Meetings Shukra Pharmaceuticals Key Metrics Shukra Pharmaceuticals Shareholdings Shukra Pharmaceuticals Profit Loss Shukra Pharmaceuticals Balance Sheet Shukra Pharmaceuticals Q1 Results Shukra Pharmaceuticals Q2 Results Shukra Pharmaceuticals Q3 Results Shukra Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks